© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Apr 15, 2014, the consensus forecast amongst 45 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 24 analysts offering 12 month price targets for
|Div growth (TTM)||+5.41%|
On Feb 05, 2014,
The next earnings announcement is expected on Apr 30, 2014. View Full Interim Financials
|Average growth rate||-1.05%|
|Average growth rate||-1.42%|
GlaxoSmithKline plc had 4th quarter 2013 revenues of 6.9060bn. This bettered the 6.8383bn consensus of the 8 analysts covering the company. This was 6.08% above the prior year's 4th quarter results. View Full Interim Financials
|Average growth rate||+0.46%|
GlaxoSmithKline plc had revenues for the full year 2013 of 26.5050bn. This was 0.28% above the prior year's results. View Full Annual Financials
|Average growth rate||-1.67%|